Recent developments in 5-HT3 receptor pharmacology

Trends in Pharmacological Sciences

Volumn 34, Issue 2, 2013, Pages 100-109

  Thompson, Andrew J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

5 HT3; agonist; antagonist; binding site; competitive; non competitive

Indexed keywords

ABSINTHOL; ANANDAMIDE; BEMESETRON; BILOBALIDE; CANNABIDIOL; CHLOROQUINE; CLOZAPINE; DILTIAZEM; DOLASETRON MESILATE; DRONABINOL; GINKGOLIDE A; GINKGOLIDE B; GRANISETRON; INDISETRON; INHALATION ANESTHETIC AGENT; IRINOTECAN; MEFLOQUINE; METHADONE; MORPHINE; ONDANSETRON; PALONOSETRON; PICROTOXININ; QUININE; RESVERATROL; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; TROPISETRON; TUBOCURARINE CHLORIDE; UNINDEXED DRUG; VARENICLINE;

BINDING AFFINITY; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CONSTIPATION; DRUG BINDING SITE; DRUG HALF LIFE; DRUG PENETRATION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; HUMAN; IC 50; NAUSEA; NAUSEA AND VOMITING; NONHUMAN; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; TOBACCO DEPENDENCE; UNSPECIFIED SIDE EFFECT;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; HUMANS; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN 5-HT3 RECEPTOR AGONISTS; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS;

EID: 84873386060     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2012.12.002     Document Type: Review

References (75)

1. 3 receptor, a serotonin-gated ion channel Science 254 1991 432 437
2. P.A. Davies The 5-HT3B subunit is a major determinant of serotonin-receptor function Nature 397 1999 359 363
3. 3 receptors: potential of individual isoforms for personalised therapy Curr. Opin. Pharmacol. 11 2011 81 86
4. 3 receptors: role in disease and target of drugs Pharmacol. Ther. 128 2010 146 169
5. J. Peters 5-HT3 Receptor J. Kew, C. Davies, Ion Channels: From Structure to Function 2009 Oxford University Press 231 251
6. 3 receptor internalization and causes prolonged inhibition of receptor function Eur. J. Pharmacol. 626 2010 193 199
7. R.V. Boccia Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study Support. Care Cancer 19 2011 1609 1617
8. 3 receptor as a therapeutic target Expert Opin. Ther. Targets 11 2007 527 540
9. 3 receptor ACS Med. Chem. Lett. 2 2011 571 576
10. E. Morelli Specific targeting of peripheral serotonin 5-HT3 receptors. Synthesis, biological investigation, and structure-activity relationships J. Med. Chem. 52 2009 3548 3562
11. 3 receptor with quipazine-like arylpiperazine ligands. The journey track at the end of the first decade of the third millennium Curr. Top. Med. Chem. 10 2010 504 526
12. 4 ligands: an update of medicinal chemistry research in the last few years Curr. Med. Chem. 17 2010 334 362
13. F.G. Boess Ultrastructure of the 5-hydroxytryptamine3 receptor J. Neurochem. 64 1995 1401 1405
14. A.J. Thompson The structural basis of function in Cys-loop receptors Q. Rev. Biophys. 43 2010 449 499
15. C.A. Brady Pharmacological comparison of human homomeric 5-HT3A receptors versus heteromeric 5-HT3A/3B receptors Neuropharmacology 41 2001 282 284
16. 3 receptors Proc. Natl. Acad. Sci. U.S.A. 102 2005 12595 12600
17. 3AB receptor Biophys. J. 98 2010 1494 1502
18. 3AB receptors J. Physiol. 589 2011 4243 4257
19. S.M. Kedrowski 1-Oxo-5-hydroxytryptamine: a surprisingly potent agonist of the 5-HT3 (serotonin) receptor Org. Lett. 9 2007 3205 3207
20. C.G. Jorgensen Discovery of benzamide analogues as a novel class of 5-HT receptor agonists ChemMedChem 6 2011 725 736
21. 3 receptors, and reveals that size and electronegativity at the 5 position of tryptamine are critical for efficient receptor function Eur. J. Pharmacol. 580 2008 291 297
22. 3 receptor trafficking in live cells: from biosynthesis to endocytosis J. Biol. Chem. 279 2004 53346 53352
23. 3 receptor Bioorg. Med. Chem. Lett. 22 2012 1151 1155
24. 3 receptor subunit heterogeneity from a computational point of view Phys. Chem. Chem. Phys. 14 2012 12625 12636
25. 3 receptors Eur. J. Med. Chem. 45 2010 4746 4760
26. 3 receptor internalization in enteric neurons in rat ileum Gastroenterology 131 2006 97 107
27. P.A. St John Agonists cause endocytosis of nicotinic acetylcholine receptors on cultured myotubes J. Neurobiol. 49 2001 212 223
28. 3AB receptors J. Pharmacol. Exp. Ther. 341 2012 350 359
29. 3 receptor in mammalian NG108-15 cells J. Physiol. 490 1996 679 690
30. R.L. Papke Molecular dissection of tropisetron, an α7 nicotinic acetylcholine receptor-selective partial agonist Neurosci. Lett. 378 2005 140 144
31. R.C. Drisdel High affinity binding of epibatidine to serotonin type 3 receptors J. Biol. Chem. 283 2008 9659 9665
32. H. Rollema Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid Neuropharmacology 52 2007 985 994
33. 3 receptor J. Pharmacol. Exp. Ther. 339 2011 125 131
34. 3 receptors PLoS ONE 4 2009 e6715
35. A.A. Jensen Ginkgolide X is a potent antagonist of anionic Cys-loop receptors with a unique selectivity profile at glycine receptors J. Biol. Chem. 285 2010 10141 10153
36. 3 receptor at a location that overlaps the picrotoxin binding site Neuropharmacology 60 2011 488 495
37. 3 receptor Mol. Pharmacol. 80 2011 183 190
38. P. Das Molecular determinants of picrotoxin inhibition of 5-hydroxytryptamine type 3 receptors J. Pharmacol. Exp. Ther. 314 2005 320 328
39. R. Hawthorne, and J.W. Lynch The molecular pharmacology of the glycine receptor H.R. Arias, Biological and Biophysical Aspects of Ligand-Gated Ion Channel Receptor Superfamilies 2006 Research Signpost 227 240
40. AR reveal a pattern of hydrogen bonding with picrotoxin Biophys. J. 94 2008 4299 4306
41. R.E. Hibbs Principles of activation and permeation in an anion-selective Cys-loop receptor Nature 474 2011 54 60
42. A receptor channel J. Gen. Physiol. 129 2007 145 159
43. R. Hawthorne A picrotoxin-specific conformational change in the glycine receptor M2-M3 loop J. Biol. Chem. 280 2005 35836 35843
44. A.J. Thompson A single amino acid determines the toxicity of Ginkgo biloba extracts FASEB J. 26 2012 1884 1891
45. C receptors Br. J. Pharmacol. 153 2008 1686 1696
46. 3 receptors Br. J. Pharmacol. 151 2007 666 677
47. 3 receptors by morphine Br. J. Pharmacol. 165 2012 693 704
48. 3 receptors Br. J. Pharmacol. 114 1995 1641 1651
49. T.Z. Deeb Direct subunit-dependent multimodal 5-hydroxytryptamine3 receptor antagonism by methadone Mol. Pharmacol. 75 2009 908 917
50. 9-tetrahydrocannabinol on 5-HT3 receptors depends on the current density Neuroscience 171 2010 40 49
51. 3A receptors varies with receptor density and desensitization Mol. Pharmacol. 73 2008 314 322
52. 3A receptor-mediated ion current in Xenopus oocytes Brain Res. 1331 2010 20 27
53. J.H. Lee Effects of triterpenoids from Poria cocos Wolf on the serotonin type 3A receptor-mediated ion current in Xenopus oocytes Eur. J. Pharmacol. 615 2009 27 32
54. 3 receptor Curr. Opin. Pharmacol. 11 2011 75 80
55. 3 receptor antagonists: current uses and future directions Pharmacol. Ther. 130 2011 338 347
56. 3 receptors: inhibition and potentiation of Cys-loop receptor signalling through a conserved transmembrane intersubunits site J. Biol. Chem. 287 2012 25241 25254
57. 3 receptor activity by an effect on the agonist-reduced desensitization Neuropharmacology 46 2004 192 201
58. 3A receptor is a molecular determinant of allosteric modulation by 5-hydroxyindole Neuropharmacology 54 2008 1153 1165
59. A.N. de Oliviera-Pierce Colchicine: a novel positive allosteric modulator of the human 5-hydroxytryptamine3A receptor J. Pharmacol. Exp. Ther. 329 2009 838 847
60. B.H. Lee Resveratrol enhances 5-hydroxytryptamine type 3A receptor-mediated ion currents: the role of arginine 222 residue in pre-transmembrane domain I Biol. Pharm. Bull. 34 2011 523 527
61. A.G. Hope Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-AS) subunit stably expressed in HEK 293 cells Br. J. Pharmacol. 118 1996 1237 1245
62. 3A receptor reduces alcohol sensitivity Brain Res. Mol. Brain Res. 142 2005 146 150
63. 3 receptor expressed in HEK 293 cells Naunyn Schmiedebergs Arch. Pharmacol. 360 1999 225 233
64. 3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted rat Neurogastroenterol. Motil. 11 1999 207 217
65. 3A receptors: probable involvement of an allosteric modulatory site Br. J. Pharmacol. 137 2002 589 596
66. 3A receptor are specifically modified by a 5-HT3B receptor subunit J. Biol. Chem. 274 1999 30799 30810
67. K.H. Yang The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes J. Pharmacol. Exp. Ther. 333 2010 547 554
68. 3 receptor antagonists. Structure-affinity relationships of novel 1,7-annelated indole derivatives J. Med. Chem. 36 1993 3693 3699
69. 3 antagonists MDL 73147EF (dolasetron mesilate) and MDL 74156 in NG108-15 neuroblastoma × glioma cells Eur. J. Pharmacol. 219 1992 9 13
70. 4 receptors Eur. J. Pharmacol. 271 1994 159 166
71. 3AB receptor responses Biochem. Biophys. Res. Commun. 415 2011 416 420
72. 3 receptors, in vitro Br. J. Pharmacol. 114 1995 851 859
73. 3H]granisetron binding in the cloned human 5-hydroxytryptamine3 receptors Jpn. J. Pharmacol. 78 1998 381 384
74. T. Suzuki Inhibitory effect of glucocorticoids on human-cloned 5-hydroxytryptamine3A receptor expressed in Xenopus oocytes Anesthesiology 101 2004 660 665
75. 3 receptor Biophys. J. 84 2003 1720 1733